Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Treatment of recurrent or metastatic renal cell carcinoma.

Treatment of recurrent or metastatic renal cell carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Treatment of recurrent or metastatic renal cell carcinoma. Abstract Text:

    riyaz n h shahRiyaz N H Shah,tanya ahmadTanya Ahmad,tim g eisenTim G Eisen,

    The management of recurrent renal cell carcinoma is challenging as it requires close collaboration between surgeons, radiation oncologists and medical oncologists. To date, treatment options for metastatic disease have been of modest benefit. The disease has therefore been a good model for novel drug development programs. These endeavors are now bearing fruit with exciting preliminary data now emerging in relation to a number of novel agents.

    Treatment of recurrent or metastatic renal cell carcinoma. Publishing Authors By Initials

    rn shahRN Shah,t ahmadT Ahmad,tg eisenTG Eisen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Treatment of recurrent or metastatic renal cell carcinoma. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Expert review of anticancer therapy

    VOLUME: 4

    Page Numbers: 1069-80

    Journal Abbreviation: Expert Rev Anticancer Ther

    ISSN: 1744-8328

    DAY: 5

    MONTH: Dec

    YEAR: 2004

    Treatment of recurrent or metastatic renal cell carcinoma. Information

    Number of References: 114

    LANGUAGE: eng

    NlmUniqueID: 101123358

    Treatment of recurrent or metastatic renal cell carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Treatment of recurrent or metastatic renal cell carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Treatment of recurrent or metastatic renal cell carcinoma.

    AFFILIATION: Department of Medical Oncology, The Royal Marsden Hospital, Sutton SM2 5PT, UK. riyaz.shah@rmh.nhs.uk

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Rev Anticancer Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Treatment of recurrent or metastatic renal cell carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News